BX Swiss TOP 30 CHF
1.361,35
PKT
-11,88
PKT
-0,87
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.04.14 | Holcim buy | Société Générale Group S.A. (SG) | |
| 08.04.14 | Holcim buy | Société Générale Group S.A. (SG) | |
| 08.04.14 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 08.04.14 | Holcim Neutral | Citigroup Corp. | |
| 08.04.14 | Roche overweight | JP Morgan Chase & Co. | |
| 08.04.14 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.04.14 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.04.14 | Holcim buy | Deutsche Bank AG | |
| 08.04.14 | Holcim buy | Deutsche Bank AG | |
| 08.04.14 | Holcim buy | UBS AG | |
| 08.04.14 | Novartis buy | UBS AG | |
| 08.04.14 | Roche buy | UBS AG | |
| 08.04.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 08.04.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 08.04.14 | Holcim buy | UBS AG | |
| 07.04.14 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 07.04.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 07.04.14 | Holcim Neutral | JP Morgan Chase & Co. | |
| 07.04.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 07.04.14 | Holcim Hold | Deutsche Bank AG | |
| 07.04.14 | Holcim buy | Deutsche Bank AG | |
| 07.04.14 | Holcim Outperform | BNP PARIBAS | |
| 07.04.14 | Holcim Outperform | BNP PARIBAS | |
| 07.04.14 | Holcim buy | Kelper Cheuvreux | |
| 07.04.14 | Holcim buy | Kelper Cheuvreux | |
| 07.04.14 | Holcim Neutral | Credit Suisse Group | |
| 07.04.14 | Holcim Outperform | Credit Suisse Group | |
| 07.04.14 | Zurich Insurance Conviction Buy | Goldman Sachs Group Inc. | |
| 04.04.14 | Swiss Re Equal weight | Barclays Capital | |
| 04.04.14 | Zurich Insurance kaufen | JP Morgan Chase & Co. | |
| 03.04.14 | Nestlé buy | Citigroup Corp. | |
| 02.04.14 | Nestlé Outperform | Bernstein Research | |
| 02.04.14 | Roche buy | Deutsche Bank AG | |
| 02.04.14 | Novartis Hold | Deutsche Bank AG | |
| 01.04.14 | Givaudan overweight | JP Morgan Chase & Co. | |
| 01.04.14 | Novartis Neutral | JP Morgan Chase & Co. | |
| 01.04.14 | Roche overweight | JP Morgan Chase & Co. | |
| 01.04.14 | Novartis buy | UBS AG | |
| 31.03.14 | UBS overweight | JP Morgan Chase & Co. | |
| 28.03.14 | Novartis buy | UBS AG |